INTRODUCTION {#sec1}
============

The use of esophageal pressure monitoring as a surrogate for pleural pressure and, hence, the transpulmonary pressure (P~L~), which is the distending pressure of the lungs, was described in the mid-20th century. This technology has many benefits in different clinical situations during mechanical ventilation, for example to assess patient's effort when the respiratory muscles are active, to monitor the patient--ventilator interactions, and to facilitate the weaning process from mechanical ventilation \[[@refg1], [@refg2]\]. However, its use has been mostly limited to clinical research \[[@refg1]\]. The recent international Safe Lung study \[[@refg3]\] revealed that such technology is rarely used in Acute Respiratory Distress Syndrome (ARDS) patients. Increased interest in using such technology arose after a 2008 study \[[@refg4]\] used esophageal pressure monitoring to set inspiratory pressures and positive end expiratory pressure (PEEP) in ARDS using the transpulmonary pressure (P~L~). According to the study protocol, the end inspiratory P~L~ was kept under 25 cmH~2~0 and the end expiratory P~L~ between 0 and 10 cmH~2~0. Using such a strategy resulted in improved oxygenation, compliance, and trend towards improved mortality. Our understanding of ventilator-induced lung injury (VILI) has markedly advanced over the last decade \[[@refg5]\]. The use of the esophageal balloon monitoring during mechanical ventilation is most appealing and has a physiologically sound base to avoid lung stress and strain, thus reducing VILI. Given those benefits, many ventilator manufacturers have incorporated esophageal pressure monitoring in their products. To our knowledge, this strategy has not been duplicated in any of the nonconventional modes of ventilation such as airway pressure release ventilation (APRV). We aimed to test the esophageal balloon in APRV and the resultant P~L~, especially the end expiratory P~L~, with different release times (T~Low~).

Introduced in the mid-1980s, APRV is considered by many as a nonconventional mode of ventilation \[[@refg6]\]. APRV is an inverse ratio, pressure controlled, intermittent mandatory ventilation with unrestricted spontaneous breathing \[[@refg7]\] that is mainly used as an alternative mode of ventilation in the difficult to oxygenate patient. APRV has many potential benefits described elsewhere \[[@refg5]\] and beyond the scope of this paper. Briefly, it is the use of a long inspiratory pressure phase (P~High~) that maintains alveolar recruitment. In addition, the expiratory pressure phase (P~Low~) and the release time (T~Low~) are kept very short to create auto-PEEP and to prevent end expiratory volume loss and alveolar derecruitment \[[@refg8]\]. However, setting APRV has been a subject of much debate \[[@refg7]\], especially the lack of consensus regarding its settings \[[@refg9]\].

Patient and Methods {#sec1.1}
-------------------

No ethics review committee approval was needed given the nature of the case report. The patient signed an approval to publish the case, and no personal information or photographs of the patient were included.

A 61-year-old obese male was admitted to the hospital with bilateral severe community-acquired pneumonia leading to acute respiratory failure and severe ARDS with PaO~2~/FiO~2~ of 75. He was managed with pressure-targeted controlled mechanical ventilation (PCV--CMV), to target a tidal volume (VT) 6 mL/kg ideal body weight, and PEEP was adjusted to 15 cmH~2~O to maintain oxygen saturation of 90%. However, because of high oxygen requirements (FiO~2~), an esophageal balloon was inserted according to the manufacturer's guidelines (Hamilton Medical AG, Switzerland). The ventilator settings were adjusted to keep inspiratory P~L~ below 20 cmH~2~O and expiratory P~L~ 0--5 cmH~2~O ([Figure 1](#fig1){ref-type="fig"}).

![Ventilator graphics display during pressure-controlled ventilation. On the X axis from top to bottom: airway pressure, esophogeal pressure, and transpulmonary pressure, all in cmH2O. Y axis is time in seconds.](cjrt-2018-010-g001){#fig1}

The ventilator mode was changed to APRV as follows: P~High~ was set to 30 cmH~2~O (same as inspiratory pressure on PCV), P~Low~ was set at 0 cmH~2~O, T~Low~ started at 0.1 s and increased by increments of 0.1 to 0.7 s, the release number was 10 s, with each cycle 6 s. T~High~ was variable from 5.9 to 5.3 s relative to the incremental increased T~Low~. We measured and recorded the airway pressure, esophageal pressure, inspiratory and expiratory P~L~, VT, expiratory flow, and percentage decay of expiratory flow from peak expiratory flow (PEF) at the end of the T~Low~. Each setting was recorded for 2 min.

RESULTS {#sec2}
=======

The results are summarized in [Figure 2](#fig2){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}. At all levels of T~Low~ from 0.1 to 0.7 s, the expiratory P~L~ was constantly a negative value indicating alveolar collapse. The expiratory flow at the end of the releases ranged from 75% to 87%.

###### Patient test results

                                      T~Low~ (s)                            
  ----------------------------------- ------------ ---- ---- ---- ---- ---- ----
  Airway pressure (cmH~2~O)           11           10   10   9    9    8    8
  Esophogeal pressure (cmH~2~O)       18           17   15   14   14   13   12
  Transpulmonary pressure (cmH~2~O)   −7           −7   −5   −5   −5   −5   −4
  \% PEF                              87           85   83   81   80   78   75

\% PEF, percentage of decay of peak expiratory flow at the end of the release time; T~Low~, time low or release time in seconds.

![Ventilator graphics display during APRV showing summary of airway pressure, esophogeal pressure, transpulmonary pressure, all in cmH2O and flow in L/min, on X axis during different release times (0.1 -- 0.7 s). Y axis is time in seconds.](cjrt-2018-010-g002){#fig2}

DISCUSSION {#sec3}
==========

The concept of using an esophageal pressure monitoring to guide setting mechanical ventilation, especially PEEP, has been on the rise and gaining momentum over the last decade. Research has shown that setting PEEP during conventional mechanical ventilation to maintain a positive P~L~ at end of expiration improves oxygenation, respiratory compliance, and the trend towards improved mortality \[[@refg4]\]. No such research was duplicated with the use of APRV. APRV setting, especially T~Low~, has been the subject of much debate and confusion. The concept of T~Low~ is to create a short release time creating auto-PEEP to avoid volume loss and alveolar dercruitment at end of expiration. In our 2012 review article \[[@refg7]\], we described in detail the different methods of setting T~Low~ in APRV with the relative advantages and disadvantages of each method. Briefly, it has been suggested to set T~Low~ empirically in a range of 0.2--0.8 s \[[@refg8], [@refg10]\], but some have advocated to set it to achieve 50% -- 75% of PEF \[[@refg8]\]. Another study suggested to set it according to a certain time constant (τ) (calculated as the product of the static respiratory compliance and resistance) and to adjust it for a certain tidal volume per release \[[@refg11]\]. DiRocco et al. \[[@refg12]\] suggested that alveolar derecruitment still occurs despite short release time in APRV in an animal model of lung injury.

We previously found that the expiratory flow decay and, hence, auto-PEEP created during APRV is variable depending on the ventilator manufacturer and thus may not be reliable \[[@refg13]\]. Similarly, another bench study that compared three different methods of setting T~Low~ described the challenges and the unpredictability of auto-PEEP in APRV \[[@refg14]\].

In a recently published APRV review \[[@refg15]\], we called for research using innovative ways to set APRV, including the use of esophageal pressure monitoring or measuring the functional residual capacity. To our knowledge this is the first attempt to investigate the P~L~ in APRV. Kollisch-Singule et al. \[[@refg16]\] recently used esophageal balloon monitoring in APRV to monitor respiratory mechanics in an animal model of extra-pulmonary lung injury with no mention of P~L~ during the T~Low~.

Our case is just "food for thought" and hopefully will encourage more research into this controversial and critical aspect of setting APRV. An intriguing observation in our case is that the esophageal pressure change during the release did not parallel the airway pressure ([Figure 2](#fig2){ref-type="fig"}) though as expected the drop increased steadily from 0.1 to 0.7 s because of the different compliances and resulting time constants between the lung and the chest wall. Our patient's total respiratory system compliance (C~RS~), calculated as the tidal volume divided by plateau pressure (obtained during brief inspiratory pause) -- total PEEP, was 50 mL/cmH~2~0; the chest wall compliance (C~CW~), calculated as tidal volume divided by esophageal/pleural pressure (P~PL~), was 29 mL/cmH~2~O; and finally lung compliance (C~L~), calculated as C~RS~ -- C~CW~,was  21 mL/cmH~2~O ([Figure 3](#fig3){ref-type="fig"}). The worst compliance of the lung would mean faster emptying and collapse compared with the higher chest  wall compliance. Furthermore, an important issue not to be missed, as our patient τ was 0.2 s (calculated as compliance × resistance, i.e.,  0.05 L/cmH~2~O × 4 cmH~2~O/L/s), the expiratory flow did not decay by 63.2% each 0.2 s to almost reach zero at 4 time constants of 0.8 s as expected per a mathematical method previously published \[[@refg7]\] ([Figure 4](#fig4){ref-type="fig"}).

![Ventilator graphics display during volume-controlled ventilation with an inspiratory hold maneuver to calculate the static compliance of respiratory system and airway resistance. On the X axis from top to bottom: airway pressure, esophogeal pressure, and transpulmonary pressure all in cmH2O. Y axis is time in seconds.](cjrt-2018-010-g003){#fig3}

![Lung simulator diagram of airway pressure release ventilation: volume (yellow), lung pressure (white), and flow (orange)/time curve. Time constant (TC) was known and the TLow was set to more than 4 TCs. The blue vertical lines represent each TC. Intrinsic PEEP at each TC would be equal to the point intersecting with the pressure curve, or it can be calculated as the end expiratory lung volume divided by respiratory compliance. Notice that at each TC the flow curve did not decay to 36.2% from its previous value as expected per the mathematical model. Reproduced with permission from Respiratory Care \[[@refg5]\].](cjrt-2018-010-g004){#fig4}

This finding confirms our previous observation that the flow decay differs with the ventilator model and from the mathematical theory to the bedside \[[@refg13]\]; therefore, using the time constant to set T~Low~ may not be accurate.

Our case has some limitations in addition to the inherit limitation of the esophageal balloon pressure monitoring. (*i*) This is a single patient report with a short observation time. (*ii*) The P~High~ and the T~Low~ were kept constant and were not adjusted, so consequently the T~High~ got shorter each time the T~Low~ was increased. In retrospect we might have needed to change those variables to evaluate if that would have an effect on the expiratory P~L~. (*iii*) The exact amount of auto-PEEP in APRV is hard to obtain or calculate at the bedside, and doing an expiratory hold maneuver at the end of the release was never documented as the accepted way to measure total PEEP or the auto-PEEP if using P~Low~ of 0 cmH~2~O. Consequently, we did not apply an expiratory hold at the end of the release. [Figure 5](#fig5){ref-type="fig"} shows an expiratory hold maneuver in a different patient on APRV.

![Ventilator graphic display during APRV with an expiratory hold maneuver to calculate auto-PEEP, total PEEP, and end expiratory transpulmonary pressure at the end of the release time. On the X axis from top to bottom: airway pressure, esophageal pressure, and transpulmonary pressure all in cmH2O and flow in L/min. Y axis is time in seconds.](cjrt-2018-010-g005){#fig5}

The expiratory P~L~ is negative using the airway pressure at the T~Low~, but it is positive at the end of the expiratory hold. In theory, calculating the P~L~ after the expiratory pause is the most appropriate way to set the T~Low~. This dilemma needs to be further investigated.

Hopefully new research and observations take into account these limitations.

CONCLUSION {#sec4}
==========

Setting APRV, especially the T~Low~, with the aid of esophageal balloon to measure P~L~ is conceptually valuable and relatively feasible.

Setting T~Low~ in APRV according to the percentage of PEF might not be a valid method of avoiding alveolar collapse. More studies are needed to confirm these findings.
